Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in children

Blood. 2021 Jan 7;137(1):138-141. doi: 10.1182/blood.2020006807.

Marie Nolla¹, Nathalie Aladjidi^{2

3}, Thierry Leblanc⁴, Helder Fernandes^{2

3}, Stéphane Ducassou^{2

3}, Mony Fahd⁴, Vincent Barlogis⁵, Marc Michel⁶, Pascale Blouin⁷, Eric Jeziorski⁸, Joy Benadiba⁹, Corinne Pondarre¹⁰, Guy Leverger¹¹, Marlene Pasquet^{1

12}

¹ Pediatric Oncology Hematology Unit, University Hospital, Toulouse, France.
² Pediatric Oncology Hematology Unit, CIC 1401, INSERM CICP, and.
³ Centre de référence national des cytopénies autoimmunes de l'enfant, University Hospital, Bordeaux, France.
⁴ Pediatric Hematology and Immunology Unit, Assistance Publique des Hôpitaux de Paris, Hôpital Robert-Debré, Paris, France.
⁵ Pediatric Oncology Hematology Unit, University Hospital de la Timone, Marseille, France.
⁶ Department of Internal Medicine, Henri Mondor University Hospital, Assistance Publique des Hôpitaux de Paris, Université Paris-Est Crétéil, Créteil, France.
⁷ Pediatric Oncology Hematology Unit, University Hospital, Nantes, France.
⁸ Pediatric Immunology and Infectious Disease Unit, Montpellier, France.
⁹ Pediatric Oncology and Hematology, Nice, France.
¹⁰ Pediatric Hematology, CHIC, Creteil, France.
¹¹ Pediatric Oncology Hematology Unit, Assistance Publique des Hôpitaux de Paris-Hôpital Trousseau, Unité INSERM UMRS_938, Paris, France; and.
¹² CRCT, Team 16, IUCT-Oncopole, Toulouse, France.

No abstract available

Publication types